tiprankstipranks
Trending News
More News >
ASKA Pharmaceutical Holdings Co., Ltd. (JP:4886)
:4886
Japanese Market

ASKA Pharmaceutical Holdings Co., Ltd. (4886) Ratios

Compare
0 Followers

ASKA Pharmaceutical Holdings Co., Ltd. Ratios

JP:4886's free cash flow for Q3 2024 was ¥0.49. For the 2024 fiscal year, JP:4886's free cash flow was decreased by ¥ and operating cash flow was ¥0.12. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
2.34 3.05 3.10 2.39 2.18
Quick Ratio
1.49 2.04 2.15 1.53 1.36
Cash Ratio
0.57 0.82 0.76 0.63 0.43
Solvency Ratio
0.35 0.23 0.21 0.16 0.11
Operating Cash Flow Ratio
0.06 0.19 0.18 0.39 -0.03
Short-Term Operating Cash Flow Coverage
0.30 0.97 1.65 2.47 -0.18
Net Current Asset Value
¥ 27.33B¥ 21.15B¥ 15.15B¥ 1.86B¥ -1.34B
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.14 0.17 0.20 0.20
Debt-to-Equity Ratio
0.15 0.23 0.29 0.37 0.39
Debt-to-Capital Ratio
0.13 0.19 0.22 0.27 0.28
Long-Term Debt-to-Capital Ratio
0.07 0.14 0.20 0.24 0.25
Financial Leverage Ratio
1.47 1.60 1.70 1.86 1.93
Debt Service Coverage Ratio
2.04 2.04 3.26 2.26 1.78
Interest Coverage Ratio
162.50 102.16 85.63 61.19 23.56
Debt to Market Cap
0.16 0.38 0.39 0.40 0.40
Interest Debt Per Share
336.42 448.78 497.07 579.96 582.66
Net Debt to EBITDA
-0.34 -0.23 0.25 0.84 1.73
Profitability Margins
Gross Profit Margin
48.80%47.28%46.55%46.00%45.71%
EBIT Margin
15.76%8.94%10.99%6.54%2.87%
EBITDA Margin
20.00%13.62%13.57%12.63%10.03%
Operating Profit Margin
10.34%8.45%8.47%6.54%2.87%
Pretax Profit Margin
15.69%8.86%10.89%6.48%1.71%
Net Profit Margin
12.01%7.01%7.58%4.92%1.24%
Continuous Operations Profit Margin
12.01%7.01%7.58%4.92%1.24%
Net Income Per EBT
76.51%79.11%69.61%75.89%72.03%
EBT Per EBIT
151.72%104.87%128.53%99.03%59.75%
Return on Assets (ROA)
8.31%4.86%5.15%3.29%0.81%
Return on Equity (ROE)
12.18%7.77%8.77%6.10%1.56%
Return on Capital Employed (ROCE)
9.73%7.35%7.13%5.48%2.39%
Return on Invested Capital (ROIC)
6.93%5.54%4.84%4.00%1.65%
Return on Tangible Assets
8.59%5.13%5.56%3.84%0.97%
Earnings Yield
12.34%12.62%11.97%6.55%1.57%
Efficiency Ratios
Receivables Turnover
4.03 3.97 3.91 4.20 3.81
Payables Turnover
4.37 11.23 9.70 4.62 4.72
Inventory Turnover
1.58 1.80 2.01 2.07 2.03
Fixed Asset Turnover
5.58 5.60 5.18 4.35 3.88
Asset Turnover
0.69 0.69 0.68 0.67 0.65
Working Capital Turnover Ratio
1.84 1.74 2.00 2.54 2.63
Cash Conversion Cycle
238.48 261.89 237.45 183.98 198.20
Days of Sales Outstanding
90.48 91.86 93.38 87.00 95.81
Days of Inventory Outstanding
231.42 202.53 181.69 176.04 179.68
Days of Payables Outstanding
83.43 32.50 37.62 79.07 77.29
Operating Cycle
321.91 294.39 275.07 263.05 275.49
Cash Flow Ratios
Operating Cash Flow Per Share
52.48 118.67 100.18 230.55 -17.39
Free Cash Flow Per Share
1.17 92.25 16.39 191.64 -97.42
CapEx Per Share
51.32 26.42 83.79 38.91 80.03
Free Cash Flow to Operating Cash Flow
0.02 0.78 0.16 0.83 5.60
Dividend Paid and CapEx Coverage Ratio
0.66 2.80 1.02 4.12 -0.18
Capital Expenditure Coverage Ratio
1.02 4.49 1.20 5.92 -0.22
Operating Cash Flow Coverage Ratio
0.16 0.27 0.20 0.40 -0.03
Operating Cash Flow to Sales Ratio
0.02 0.06 0.05 0.12 >-0.01
Free Cash Flow Yield
0.05%7.76%1.30%13.12%-6.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
8.11 7.92 8.35 15.28 63.68
Price-to-Sales (P/S) Ratio
0.97 0.56 0.63 0.75 0.79
Price-to-Book (P/B) Ratio
0.99 0.62 0.73 0.93 0.99
Price-to-Free Cash Flow (P/FCF) Ratio
1.85K 12.89 77.06 7.62 -15.00
Price-to-Operating Cash Flow Ratio
41.15 10.02 12.61 6.34 -84.00
Price-to-Earnings Growth (PEG) Ratio
0.10 -10.51 0.14 0.05 -1.01
Price-to-Fair Value
0.99 0.62 0.73 0.93 0.99
Enterprise Value Multiple
4.53 3.85 4.92 6.79 9.58
Enterprise Value
EV to EBITDA
4.53 3.85 4.92 6.79 9.58
EV to Sales
0.91 0.52 0.67 0.86 0.96
EV to Free Cash Flow
1.72K 12.17 81.24 8.71 -18.31
EV to Operating Cash Flow
38.29 9.46 13.29 7.24 -102.55
Tangible Book Value Per Share
2.09K 1.77K 1.51K 1.15K 989.50
Shareholders’ Equity Per Share
2.19K 1.93K 1.72K 1.57K 1.47K
Tax and Other Ratios
Effective Tax Rate
0.23 0.21 0.30 0.24 0.28
Revenue Per Share
2.22K 2.14K 2.00K 1.94K 1.86K
Net Income Per Share
266.49 150.08 151.22 95.63 22.94
Tax Burden
0.77 0.79 0.70 0.76 0.72
Interest Burden
1.00 0.99 0.99 0.99 0.60
Research & Development to Revenue
0.08 0.07 0.06 0.00 0.09
SG&A to Revenue
0.21 0.22 0.22 0.00 0.22
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.20 0.63 0.46 2.41 -0.76
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis